Precision BioSciences, Inc. (DTIL)

USD 4.13

(-9.83%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue 48.72 Million 25.09 Million 115.52 Million 24.28 Million 22.23 Million 10.88 Million
Cost of Revenue 8.25 Million 9 Million - - - -
Gross Profit 40.47 Million 16.09 Million 115.52 Million 24.28 Million 22.23 Million 10.88 Million
Operating Expenses 92.46 Million 125.46 Million 154.93 Million 134.11 Million 109.44 Million 58.79 Million
Selling, General and Administrative Expenses 39.08 Million 41.52 Million 39.69 Million 36.05 Million 27.02 Million 13.67 Million
Research and Development Expenses 49.35 Million 83.93 Million 115.23 Million 98.06 Million 82.41 Million 45.12 Million
Other Expenses - - - - -9.75 Million -
Cost and Expenses 92.46 Million 125.46 Million 154.93 Million 134.11 Million 109.44 Million 58.79 Million
Operating Income -43.73 Million -100.36 Million -39.4 Million -109.82 Million -87.2 Million -47.91 Million
Interest Expense 2.23 Million 1.11 Million 132 Thousand - 182 Thousand -
Income Tax Expense - 11.27 Million 316 Thousand 10.42 Million -9.57 Million 1.87 Million
Earnings before Tax -42.52 Million -111.63 Million -30.6 Million -109 Million -92.87 Million -46.03 Million
Net Income -61.31 Million -122.9 Million -30.91 Million -109 Million -83.3 Million -46.03 Million
Earnings Per Share Basic -15.96 -41.95 -15.80 -62.85 -59.50 -28.17
Earnings Per Share Diluted -15.96 -41.95 -15.80 -62.85 -59.50 -28.17
Weighted Average Shares Outstanding 3.84 Million 2.92 Million 1.95 Million 1.73 Million 1.4 Million 1.63 Million
Weighted Average Shares Outstanding (Diluted) 3.84 Million 2.92 Million 1.95 Million 1.73 Million 1.4 Million 1.63 Million
Gross Margin 0.83 0.64 1.00 1.00 1.00 1.00
EBIT Margin -0.66 -3.92 -0.25 -4.08 -3.93 -4.19
Profit Margin -1.26 -4.90 -0.27 -4.49 -3.75 -4.23
EBITDA -32.04 Million -62.79 Million -20.27 Million -99.19 Million -87.37 Million -43.68 Million
Earnings Before Tax Margin -0.90 -4.00 -0.34 -4.52 -3.92 -4.40

Income Statement Charts